BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34269910)

  • 1. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
    Isaac KM; Portell CA; Williams ME
    Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
    Beà S; Amador V
    Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
    Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
    Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.
    Hu Z; Sun Y; Schlette EJ; Tang G; Li S; Xu J; Yin CC; Young KH; Patel KP; Miranda RN; Goswami M; Wang M; Jorgensen JL; Medeiros LJ; Wang SA
    Mod Pathol; 2018 Feb; 31(2):327-336. PubMed ID: 28984300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
    Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
    Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive and specific
    Federmann B; Frauenfeld L; Pertsch H; Borgmann V; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
    Haematologica; 2020 Mar; 105(3):754-764. PubMed ID: 31296581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
    Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
    Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
    Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
    Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX11, a key oncogenic factor in mantle cell lymphoma.
    Beekman R; Amador V; Campo E
    Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathogenesis of Mantle Cell Lymphoma.
    Navarro A; Beà S; Jares P; Campo E
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.
    Clot G; Jares P; Giné E; Navarro A; Royo C; Pinyol M; Martín-Garcia D; Demajo S; Espinet B; Salar A; Ferrer A; Muntañola A; Aymerich M; Rauert-Wunderlich H; Jaffe ES; Connors JM; Gascoyne RD; Delabie J; López-Guillermo A; Ott G; Wright GW; Staudt LM; Rosenwald A; Scott DW; Rimsza LM; Beà S; Campo E
    Blood; 2018 Jul; 132(4):413-422. PubMed ID: 29769262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
    Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
    Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
    Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
    Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
    Ondrejka SL; Lai R; Smith SD; Hsi ED
    Haematologica; 2011 Aug; 96(8):1121-7. PubMed ID: 21508124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
    Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
    Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX11 expression in mantle cell lymphoma.
    Xu W; Li JY
    Leuk Lymphoma; 2010 Nov; 51(11):1962-7. PubMed ID: 20919851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
    Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
    Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
    Jing C; Zheng Y; Feng Y; Cao X; Xu C
    Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
    Orchard J; Garand R; Davis Z; Babbage G; Sahota S; Matutes E; Catovsky D; Thomas PW; Avet-Loiseau H; Oscier D
    Blood; 2003 Jun; 101(12):4975-81. PubMed ID: 12609845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes.
    Nodit L; Bahler DW; Jacobs SA; Locker J; Swerdlow SH
    Hum Pathol; 2003 Oct; 34(10):1030-4. PubMed ID: 14608537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.